Document is current
Any future updates will be listed below
-
Authors
Iguchi, Taro
Tamada, Satoshi
Kato, Minoru
Yasuda, Sayaka
Yamasaki, Takeshi
Nakatani, Tatsuya
-
Funding
Funding for this research was provided by:
Astellas Pharma
- License Information
-
More Information
Article History
Received: 21 November 2017
Accepted: 27 March 2019
First Online: 11 April 2019
Ethics approval and consent to participate
: The OCUU-CRPC study was approved by ethical committee in Osaka City University Graduate School of Medicine on September 292,014 (reference number: 2936) while the study protocol was amended on November 282,016 (ver. 5), and subsequently from the institutional ethics committees of all other participating 16 hospitals listed below; Bellland General Hospital: Approved on 23 Feb 2015. Fuchu Hospital: Approved on 17 Dec 2014. Ikuwakai Memorial Hospital: Approved on 3 Feb 2015. Ishikiriseiki Hospital: Approved on 9 Jan 2015. Itami Municipal Hospital: Approved on 18 May 2015. Meijibashi Hospital: Approved on 8 Jun 2015. Minamiosaka Hospital: Approved on 19 Dec 2014. Ohno Memorial Hospital: Approved on 26 Feb 2015. Osaka City General Hospital: Approved on 11 May 2015. Osaka City Juso Hospital: Approved on 30 Jan 2015. Osaka General Hospital of West Japan Railway Company: Approved on 13 Jan 2016. PL Hospital: Approved on 7 Sep 2015. Shirasagi Hospital: Approved on 24 Feb 2015. Suita Municipal Hospital: Approved on 7 Aug 2015. Yao Municipal Hospital: Approved on 16 Jan 2015. Yao Tokushukai General Hospital: Approved on 22 Jun 2015.
: Not applicable.
: T. Iguchi and T. Nakatani have research funding from Astellas pharma Inc. and Bayer Yakuhin, Ltd. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
